Spruce Biosciences

SPRBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$128.999 M

$46.87 +0.97%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$39.0M

Loss-making

Shares outstanding

1,372,043

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#294ProMIS NeurosciencesPMN$131.9M
#295NRX PharmaceuticalsNRXP$129.7M
#296Spruce BiosciencesSPRB$129.0M
#297Tiziana Life SciencesTLSA$127.3M
#298BGM GroupBGM$120.3M

Where these numbers come from

Share counts and financials for Spruce Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.